Neutrophil chemiluminescence during phagocytosis is inhibited by abnormally elevated levels of acetoacetate: Implications for diabetic susceptibility to infections

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 5, 1998, Pages 740-743

  Saeed, Fawzia A ^a,b   Castle, Georgina E ^a  

^a SAINT MARY'S COLLEGE OF CALIFORNIA   (United States)

^b St Mary's College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOACETIC ACID; MYELOPEROXIDASE;

ARTICLE; CHEMOLUMINESCENCE; DIABETES MELLITUS; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION SENSITIVITY; KETOACIDOSIS; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0032406220     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.5.740-743.1998     Document Type: Article

References (13)

1. Babior, B. M., R. S. Kipnes, and J. T. Curnutte. 1973. Biological defense mechanism: the production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Investig. 52:741-744.
2. Harrison, J. E., and F. A. Saeed. 1981. Acetoacetate is an electron donor to myeloperoxidase and a promoter of myeloperoxidase-catalyzed fatty acid peroxidation. Biochem. Med. 26:339-355.
3. Harrison, J. E., and F. A. Saeed. 1981. Acetoacetate: an electron donor and halogen acceptor for neutrophil myeloperoxidase and a promoter of fatty acid peroxidation. In ACS Annual Meeting Abstracts.
4. Harrison, J. E., and F. A. Saeed. 1983. Radical acetoacetate oxidation by myeloperoxidase, lactoperoxidase, prostaglandin synthetase, and prostacyclin synthetase: implications for atherosclerosis. Biochem. Med. 29:149-163.
5. Harrison, J. E., and J. Schultz. 1976. Studies on the chlorinating mechanism of myeloperoxidase. J. Biol. Chem. 251:1371-1374.
6. 5a. Kankaanranta, H., E. Moilanen, K. Lindberg, and H. Vapaatalo. 1995. Pharmacological control of human polymorphonuclear leukocyte degranulation by fenamates and inhibitors of receptor-mediated calcium entry and protein kinase C. Biochem. Pharmacol. 50(2):197-203.
7. Klebanoff, S. J., and R. A. Clark. 1978. The neutrophil: functional and clinical disorders. Elsevier Scientific Publications, Amsterdam, The Netherlands.
8. Lehrer, R. I., and M. J. Cline. 1969. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infections. J. Clin. Investig. 48:1478.
9. Lehrer, R. I., and M. J. Cline. 1969. Interaction of Candida albicans with human leukocytes and serum. J. Bacteriol. 98:996-1004.
10. 8a. Lopez, I., D. Burns, and J. Lambeth. 1995. Regulation of phospholipase D by protein kinase C in human neutrophils. J. Biol. Chem. 270:19465-19472.
11. Rhoades, R., and R. Pflanzer. 1996. Human physiology. Saunders College Publishing, Orlando, Fla.
12. Saeed, F. A. 1996. Inactivation of myeloperoxidase (MPO) as a basis for diabetic susceptibility to Candidiasis, abstr. 110.020, p. 278. In 7th International Congress for Infectious Diseases Abstracts.
13. Thelen, M., B. Dewald, and M. Baggiolini. 1993. Neutrophil signal transduction and activation of the respiratory burst. Physiol. Rev. 73:797-821.